| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 9, 2004
Accepted on May 3, 2004
-Estradiol Inhibits Class II MHC Expression: Influence on Histone Modifications and CBP Recruitment to the Class II MHC Promoter
Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294
* To whom correspondence should be addressed. E-mail: tika{at}uab.edu.
Major histocompatibility complex (MHC) class II proteins are important for the initiation of immune responses and are essential for specific recognition of foreign antigens by the immune system. Regulation of class II MHC expression primarily occurs at the transcriptional level. The class II transactivator (CIITA) protein is the master regulator that is essential for both constitutive and interferon-
(IFN-) inducible class II MHC expression. Estrogen (17
-E2) has been shown to have immunomodulatory effects. In this study, we show that 17-E2 downregulates IFN- inducible class II MHC protein levels on brain endothelial cells, as well as other cell types (astrocytes, fibrosacroma cells, macrophages). The inhibitory effects of 17-E2 on class II MHC expression are not due to changes in CIITA mRNA or protein levels, rather, 17-E2 mediates inhibition at the level of class II MHC gene expression. We demonstrate that 17-E2 attenuates H3 and H4 histone acetylation and CREB-binding protein (CBP) association with the class II MHC promoter, suggesting that 17-E2 inhibits class II MHC expression by a novel mechanism involving modification of the histone acetylation status of the class II MHC promoter.
NURSA Molecule Pages Link:
This article has been cited by other articles:
 |
|
 |
|
  O. I. Koues, R. K. Dudley, A. D. Truax, D. Gerhardt, K. P. Bhat, S. McNeal, and S. F. Greer Regulation of Acetylation at the Major Histocompatibility Complex Class II Proximal Promoter by the 19S Proteasomal ATPase Sug1 Mol. Cell. Biol., October 1, 2008; 28(19): 5837 - 5850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ivanga, Y. Labrie, E. Calvo, P. Belleau, C. Martel, V. Luu-The, J. Morissette, F. Labrie, and F. Durocher Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus Physiol Genomics, March 14, 2007; 29(1): 13 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Oldford, J. D. Robb, D. Codner, V. Gadag, P. H. Watson, and S. Drover Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients Int. Immunol., November 1, 2006; 18(11): 1591 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. T. Ruiz-Cortes, S. Kimmins, L. Monaco, K. H. Burns, P. Sassone-Corsi, and B. D. Murphy Estrogen Mediates Phosphorylation of Histone H3 in Ovarian Follicle and Mammary Epithelial Tumor Cells via the Mitotic Kinase, Aurora B Mol. Endocrinol., December 1, 2005; 19(12): 2991 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Lambert, E. M. Curran, B. M. Judy, G. N. Milligan, D. B. Lubahn, and D. M. Estes Estrogen Receptor {alpha} (ER{alpha}) Deficiency in Macrophages Results in Increased Stimulation of CD4+ T Cells while 17{beta}-Estradiol Acts through ER{alpha} to Increase IL-4 and GATA-3 Expression in CD4+ T Cells Independent of Antigen Presentation J. Immunol., November 1, 2005; 175(9): 5716 - 5723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Adamski and E. N. Benveniste 17{beta}-Estradiol Activation of the c-Jun N-Terminal Kinase Pathway Leads to Down-Regulation of Class II Major Histocompatibility Complex Expression Mol. Endocrinol., January 1, 2005; 19(1): 113 - 124. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
